Which has higher access to anti-retroviral drugs, female, Madagascar or Syrian Arab Republic?

Syrian Arab Republic, at 41.0% against 39.0% in Madagascar as of 2024.

What is the difference in access to anti-retroviral drugs, female between Madagascar and Syrian Arab Republic?

2.0%, with Syrian Arab Republic ahead.

How many years of comparable data are there for Madagascar and Syrian Arab Republic?

25 years are reported by both, from 2000 to 2024.

Where does this data come from?

UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Madagascar vs Syrian Arab Republic: Access to anti-retroviral drugs, female

Madagascar

39.0%

in 2024

Syrian Arab Republic

41.0%

in 2024

Madagascar rank

128th

Syrian Arab Republic rank

127th

Access to anti-retroviral drugs, female over time

Madagascar
Syrian Arab Republic

How they compare

Syrian Arab Republic currently reports 41.0% against 39.0% in Madagascar, a difference of 2.0%.

That makes Syrian Arab Republic's figure about 1.1 times Madagascar's.

Across all 25 years both countries report, Syrian Arab Republic has been ahead every year.

Madagascar ranks 128th and Syrian Arab Republic ranks 127th of 141 countries.

Syrian Arab Republic has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade	Madagascar	Syrian Arab Republic	Difference	Ahead
2000s	0.4%	5.4%	5.0%	Syrian Arab Republic
2010s	4.5%	26.9%	22.4%	Syrian Arab Republic
2020s	24.6%	41.4%	16.8%	Syrian Arab Republic

Averages of every year both report within each decade.

Frequently asked questions

Which has higher access to anti-retroviral drugs, female, Madagascar or Syrian Arab Republic?: Syrian Arab Republic, at 41.0% against 39.0% in Madagascar as of 2024.
What is the difference in access to anti-retroviral drugs, female between Madagascar and Syrian Arab Republic?: 2.0%, with Syrian Arab Republic ahead.
How many years of comparable data are there for Madagascar and Syrian Arab Republic?: 25 years are reported by both, from 2000 to 2024.
How do Madagascar and Syrian Arab Republic rank globally for access to anti-retroviral drugs, female?: Madagascar ranks 128th and Syrian Arab Republic ranks 127th of 141 countries.
Where does this data come from?: UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Madagascar vs Syrian Arab Republic: Access to anti-retroviral drugs, female. Statizoid, drawing on UNAIDS estimates. Retrieved 16 September 2026, from https://gender.statizoid.com/compare/access-to-anti-retroviral-drugs-female-percent/madagascar/syrian-arab-republic/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/compare/access-to-anti-retroviral-drugs-female-percent/madagascar/syrian-arab-republic/">Madagascar vs Syrian Arab Republic: Access to anti-retroviral drugs, female</a> — Statizoid

About this data

Indicator: Access to anti-retroviral drugs, female (%)
Unit: %
Source: UNAIDS estimates
Licence: CC BY 4.0 (World Bank Open Data)
Coverage: 160 places, 3,925 data points, 2000–2024
Last refreshed: 04 September 2026

The percentage of adult females living with HIV who are receiving antiretroviral therapy.